Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.53 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29692481 | 0.99 | CYP1A2 (0.62) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| Hydrochloric Acid SCHEMBL29692521 | 0.88 | CYP1A2 (0.56) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16436979 | 0.87 | CYP1A2 (0.61) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16436983 | 0.87 | CYP1A2 (0.61) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL29864521 | 0.87 | CYP1A2 (0.64) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16264592 | 0.86 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16264662 | 0.86 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16264624 | 0.86 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL24720378 | 0.85 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL21648307 | 0.85 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3606344-B1 | COMPOSITIONS AND METHODS COMPRISING A TRIARYL POLYAMINE | CURZA GLOBAL LLC (US) | 2022-08-17 | — | — | EP | disclosed |
| US-11352315-B2 | Compositions and methods comprising a triaryl polyamine | CURZA GLOBAL, LLC (US) | 2022-06-07 | — | — | US | disclosed |
| US-20200031757-A1 | COMPOSITIONS AND METHODS COMPRISING A TRIARYL POLYAMINE | CURZA GLOBAL, LLC (US) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352315-B2 | Compositions and methods comprising a triaryl polyamine | SRM, PARG, PARN | CYP1A2 3844/4885CYP2D6 4723/4885CYP2C19 3882/4885 |
| US-20200031757-A1 | COMPOSITIONS AND METHODS COMPRISING A TRIARYL POLYAMINE | SRM, PARG, PARN | CYP1A2 3844/4885CYP2D6 4723/4885CYP2C19 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.